A landmark federal report released in 2017 outlined what’s known about the potential health benefits and risks of marijuana use.
Tag Archives: Epilepsy
In the state of Illinois, the parents of an 11-year-old girl are suing their school district for their child to have the right to use medical marijuana on school grounds.
Texans can now access medical marijuana legally because of a law signed by Governor Abbott. In compliance with the Compassionate Use Program, the first dispensary will soon open in Schulenburg, Texas.
Medical cannabis may help children suffering from chemotherapy induced nausea as well as seizures, according to a new study published in the October edition of the medical journal Pediatrics.
After the company announced it will tap investors for money to fuel R&D (research and development) and pre-commercialization efforts for its Dravet syndrome drug, shares in Zogenix (NASDAQ: ZGNX) are rallying 10% at 2 p.m. EDT today.
A new Indiana law that allows people with certain types of epilepsy to use a marijuana-derived oil for treatment has spurred a statewide crackdown, making it more difficult for those seeking the product to obtain it.
Marijuana has thousands of years of history all across the world and in the United States. In the United States, marijuana has a history of prohibition and legalization both at the state and federal levels. Many southern states are actually taking action to join the fight for legalization. North Carolina is among one of these southern states that is moving forward with marijuana legalization.
Zynerba Pharmaceuticals Inc said on Monday its synthetic cannabis-based gel to treat epilepsy failed a mid-stage study, sending the U.S. drug developer’s shares plunging 50 percent.
An 11-year-old girl from Rowlett, Texas is taking on the United States federal government by suing them over medicinal marijuana.
The threat of increasing competition for GW Pharmaceuticals’ promising epilepsy drug took a toll on investors’ confidence last month.
RALEIGH, N.C., June 5, 2017 /Weed Wire/ – U.S. Senator Thom Tillis (R-NC) recently co-sponsored the Cannabidiol Research Expansion Act, a bill to support research initiatives on the potential benefits of substances such as cannabidiol (CBD) that are derived from marijuana.
GW Pharmaceuticals is set to file its cannabis-derived drug with U.S. regulators imminently, following publication of detailed data on its success in fighting severe childhood epilepsy.
HOBART, May 24, 2017 /Weed Wire/ — It is important to correct misleading claims made by the Greens yesterday that access to unregistered medical cannabis products will be restricted under the Controlled Access Scheme (CAS).
NEW YORK, May 24, 2017 /Weed Wire/ – After years of anecdotal claims about its benefits, the cannabis derivative cannabidiol reduced seizure frequency 39 percent for patients with Dravet syndrome—a rare, severe form of epilepsy—in the first large-scale, randomized clinical trial for the compound.
HOBART, May 23, 2017 /Weed Wire/ — The Hodgman Liberal Government is supporting Tasmanians to get access to medical cannabis through the Controlled Access Scheme from September 1.
WASHINGTON, May 1, 2017 /Weed Wire/ – Continuing his fight to help families with children suffering from debilitating forms of epilepsy, Congressman Scott Perry joined with Senator Corey Gardner (R-CO) to reintroduce the Charlotte’s Web Medical Access Act of 2017.
On April 6, 2017, both chambers of the Indiana Legislature approved measures loosening restrictions on a marijuana-derived oil used to treat epilepsy.
WASHINGTON, March 16, 2017 /Weed Wire/ — Earlier today, Attorney General Jeff Sessions told reporters that “I think medical marijuana has been hyped, maybe too much.”
SAN DIEGO, Calif., March 14, 2017 /Weed Wire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Mexico is holding a press conference in Mexico City, Mexico, today to reveal the positive results of a recent study conducted by renowned Mexican physician Dr. Saul Garza Morales on the effects of the Company’s Real Scientific Hemp Oil-X™ (RSHO-X™) product in treating children with severe epilepsy.
Peru is a conservative nation with strict drug laws and a politically right-leaning Congress, but when police raided a lab in which mothers made medical marijuana for their sick children, attitudes began to change, according to a March 2, 2017, article by Reuters.
Insys Therapeutics announced a compassionate-use program for its cannabis-based epilepsy drug, igniting optimism that the company is continuing to develop marijuana medicine.
A Duke doctor has refused to continue seeing a nine-year-old North Carolina girl because her family gives her cannabidiol oil to cope with a rare illnes. The nine-year-old, Mia Morley, has a medical condition called Lennox Gastaut Syndrome. Her father, Dylan Morley, said Dr. Muhammad Mikati’s decision was based upon the federal status of CBD oil, which is not FDA approved.
The father of a first-grade student in Aberdeen, Washington, could become the catalyst for a change in state law that would allow CBD oil at public schools. River Barclay, 7, needs CBD oil to manage a rare form of epilepsy, but state law will not allow her father to go to the school to administer the dose because medical marijuana is illegal on school property.
Let’s take a look back on this past year and see what the future holds for marijuana stocks.
Democratic Senator Jose Menendez filed Senate Bill 269 Tuesday morning. Menendez was joined by veterans, doctors and families at the State Capitol.
Ecofibre is expanding rapidly in the US market, where medicinal cannabis is now legal in over 30 states, including five which approved propositions to that effect at the last US election.
On Nov. 8, 2016, Florida voters overwhelmingly voted to approve Amendment 2, a ballot amendment that will legalize medical marijuana in the state.
On Sept. 26, 2016, GW Pharmaceuticals (Nasdaq:GWPH), a biopharma company with two promising cannabis-based medications, announced positive results for its third study in the United States on the efficacy of Epidiolex, its experimental CBD-based drug, in treating seizures associated with Lennox-Gastaut syndrome.
An experimental cannabis-derived drug has successfully treated children with severe epilepsy in a third late-stage clinical trial, sending shares in Britain’s GW Pharmaceuticals to a record high on Monday.
Florida might finally vote to legalize medical marijuana November 8. But beginning Monday, a few South Floridians will be able to use a strain of low-THC cannabis oil called Haleigh’s Hope.
A law making medical marijuana legal in Ohio is now in effect.
The phones at the Georgia Department of Public Health no longer ring off the hook with people calling to find doctors or asking questions about how the state’s medical marijuana registry works.
GW Pharmaceuticals (NASDAQ:GWPH) could be on its way to eventually winning the first U.S. approval for a marijuana-based prescription drug.
A new bill in the North Carolina legislature seeks to legalize medical marijuana. House Bill 983, filed about a month ago, is an update of previously failed legislative attempts to legalize medical marijuana in the state. It would allow medical marijuana use by “patients with terminal or chronic illnesses.” Currently, the state only allows CBD oil for epilepsy.
PHOENIX, May 24, 2016 /Weed Wire/ — Insys Therapeutics, Inc. (NASDAQ: INSY) (“Insys” or “the Company”) today announced that it has successfully completed its Phase 1/Phase 2 safety and pharmacokinetic (PK) study in pediatric subjects with treatment-resistant epilepsy.
In September 2014, The University of Utah’s Division of Pediatric Neurology and Primary Children’s Medical Center started the first of three clinical trials on the efficacy of Epidiolex, a nonpsychoactive cannabidiol-based drug from GW Pharmaceuticals (NASDAQ: GWPH).
On April 21, 2016, GW Pharmaceuticals (NASDAQ: GWPH), a biopharma company with two promising cannabis-based medications, announced it had received Orphan Drug Designation for cannabidiol in the treatment of Tuberous Sclerosis Complex.
On April 13, 2016, the Pennsylvania House of Representatives passed SB3, a bill legalizing medical marijuana in the state, and has sent the bill to Gov. Tom Wolf to sign.
In a reversal of policy, the Connecticut arm of the American Academy of Pediatrics (AAP) has reportedly gotten on board with an effort to expand medical marijuana legalization to sick children in the state.
LONDON, April 11, 2016 /Weed Wire/ — GW Pharmaceuticals plc today announced that it has commenced a Phase 3 clinical trial of Epidiolex® (cannabidiol or CBD) as an adjunctive therapy for the treatment of seizures associated with Tuberous Sclerosis Complex (TSC), a rare genetic disorder, the most common symptom of which is epilepsy.
On April 7, 2016, the South Carolina Senate Medical Affairs Committee rejected S 0672, a bill that would legalize medical marijuana for patients suffering from debilitating conditions, such as cancer, PTSD, and chronic pain.
According to the Daya Foundation, a non-profit organization that promotes alternative therapies, the largest medical cannabis farm in Latin America began harvesting its first crop on March 22, 2016.
On March 14, 2016, GW Pharmaceuticals (NASDAQ: GWPH), a biopharma company with two promising cannabis-based medications, announced positive results for the first pivotal Phase 3 study of Epidiolex, a CBD-based medicine, in treating Dravet syndrome, a severe form of pediatric epilepsy.
LONDON, March 14, 2016 /Weed Wire/ — GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces the positive results of the first pivotal Phase 3 study of its investigational medicine Epidiolex® (cannabidiol or CBD) for the treatment of Dravet syndrome.
On March 3, 2016, Shelley Gillen, a mother whose 13-year-old son suffers from severe epileptic seizures, met with Nebraska Sen. Sue Crawford in an attempt to convince the senator to support LB 643, a bill introduced by Sen. Tommy Garrett that would establish the Cannabis Compassion and Care Act.
On Feb. 24, 2016, the Parliament of Australia passed amendments to the Narcotic Drugs Act of 1967, legalizing medical marijuana in the country.
RICHMOND, Va., Feb. 17, 2016 /Weed Wire/ — Yesterday, the Virginia Senate by a vote of 37 to 2 passed SB701,a bill that would allow the production and manufacturing of Cannabidiol (CBD) oil and THC-A oil in the state.
The Australian government has introduced legislation that would amend the Narcotics Drugs Act of 1967 to allow for the legal cultivation and distribution of medical marijuana.
Iowa State Rep. Peter Cownie, R-West Des Moines, announced on Feb. 9, 2016, that he would be filing a medical cannabis bill on Feb. 10 that would allow for the cultivation and distribution of medical cannabis oil in Iowa.
According to the Daya Foundation, a non-profit organization that promotes alternative therapies, the largest medical marijuana farm in Latin America was officially launched on Jan. 18, 2016.